Glypican 1 antibody [N3C3]
|Applications||ELISA, FACS, ICC/IF, IHC-F, IHC-P, IP, WB|
Not tested in other applications.
| IHC (Formalin fixed sections)||Assay-dependent dilution
|IHC (Formalin-fixed paraffin-embedded sections)||1:100-1:1000*
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||62 kDa (note)
|Positive Controls||A431 , K562 , MCF-7 , AsPC-1 , MCF-7 , A431 (500 units PNGase F for 4 hr) , MDA-MB-231 , MDA-MB-231 (24 µg/ml Tunicamycin for 16hr) , U87-MG , ME , CM , Mouse brain , mouse fetal brain|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by antigen-affinity chromatography.|
|Full Name||glypican 1|
|Product Description||Rabbit Polyclonal antibody to Glypican 1 (glypican 1)|
|Background||Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. [provided by RefSeq]|
|Synonyms||FLJ38078 antibody, glypican antibody, GPC1 antibody, glypican proteoglycan 1 antibody, glypican-1 antibody, glypican 1 antibody|
|Immunogen||Recombinant protein encompassing a sequence within the center region of human Glypican 1. The exact sequence is proprietary.|
|Species Reactivity||Human, Mouse|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Rat, Rhesus Monkey, Bovine|
|Predict Reactivity Note||Rat (88%), Rhesus Monkey (97%), Bovine (89%)|